Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
9
×
Tags
biotech
life sciences
medical device
9
×
national blog main
san diego blog main
seattle blog main
9
×
new york blog main
raleigh-durham blog main
san francisco blog main
boston blog main
boston top stories
indiana blog main
san diego top stories
san francisco top stories
seattle top stories
boulder/denver blog main
boulder/denver top stories
clinical trials
deals
detroit blog main
detroit top stories
fda
indiana top stories
national
national top stories
new york top stories
raleigh-durham top stories
startups
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
cancer
eli lilly
amgen
bristol-myers squibb
cancer drugs
cancer immunotherapy
investing
merck
What
roundup
bio
companies
drug
company
developing
diabetes
disease
drugs
fda
make
medical
million
nash
new
news
sciences
startup
technology
tests
treatment
week
according
acquisitions
adding
aims
akcea
appetite
approval
approved
arguments
based
beta
big
biggest
bionics
biotech
biotechs
black
blood
Language
unset
unknown
Current search:
xconomy.com
×
photo
×
" medical device "
×
" seattle blog main "
×
@xconomy.com
3 years ago
Bio Roundup: SeaGen Scores, Dyne’s Debut, Microbiome Moves & More
@xconomy.com
4 years ago
Veracyte Aims to Expand Diagnostics Reach With $50M NanoString Deal
@xconomy.com
4 years ago
Biotech Roundup: Vaping Toll Rises, NASH News, Akcea Shakeup & More
@xconomy.com
4 years ago
Spine-Surgery Medtech Startup Carlsmed Merges With Imaging Company
@xconomy.com
5 years ago
At Big Neuro Meeting, Migraine Drug Competitors to Make Oral Arguments
@xconomy.com
5 years ago
Bio Roundup: NASH News, Merck Strikes, Digital Tokens & More
@xconomy.com
5 years ago
Bio Roundup: #JPM19 Notes, Loxo Buyout, Black Diamond’s Cash & More
@xconomy.com
5 years ago
Beta Bionics Secures $63M as AI-Driven “Pancreas” Heads to Key Tests
@xconomy.com
5 years ago
IPO Wave Rolls On as Five Life Science Firms Haul in $651M